doi:

DOI: 10.3724/SP.J.1206.2009.00474

Progress in Biochemistry and Biophysics (生物化学与生物物理进展) 2010/37:2 PP.138-144

Progress of Differentiating Human Embryonic Stem Cells Into Endothelial Progenitor Cells and Potential Applications*


Abstract:
Endothelial progenitor cells have great prospect for treatment of many diseases. However, derivation of endothelial progenitor cells in vitro is a major restriction for the clinical treatment. Human embryonic stem cells (hESCs) may become an alternative source of endothelial progenitor cells because of their high proliferation capability and in vitro pluripotency. Although, there are many challenges for differentiating hESCs to endothelial progenitor cells in vitro. Current understanding of this subject from recent discoveries in this field was summarized. Future work will be needed to translate these in vitro findings to clinical applications.

Key words:human embryonic stem cells, endothelial progenitor cells, differentiation, clinical applications

ReleaseDate:2014-07-21 15:11:50

Funds:This work was supported by grants from Hi-Tech Research and Development Program of China (2006AA02A107) and The Project of Beijing Municipal Science & Technology Commission(D07050701350702)



[1] Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 2005, 353(10): 999-1005

[2] Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Res, 1999, 85(3): 221-228

[3] Gehling U M, Ergun S, Schumacher U, et al. in vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 2000, 95(10): 3106-3112

[4] Lin Y, Weisdorf D J, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest, 2000, 105(1): 71-77

[5] Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells, 2006, 24(2): 221- 229

[6] Levenberg S, Golub J S, Amit M, et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA, 2002, 99(7): 4391-4396

[7] Wang L, Li L, Shojaei F, et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity, 2004, 21(1): 31-41

[8] Li Z, Suzuki Y, Huang M, et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 2008, 26(4): 864-873

[9] Kaufman D S, Hanson E T, Lewis R L, et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA, 2001, 98(19): 10716-10721

[10] Wang Z Z, Au P, Chen T, et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nature Biotech, 2007, 25(3): 317-318

[11] Yamahara K, Sone M, Itoh H, et al. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS ONE, 2008, 3(2): e1666

[12] Ferreira L S, Gerecht S, Shieh H F, et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circulation Research, 2007, 101(3): 286-294

[13] Gerecht-Nir S, Ziskind A, Cohen S, et al. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Laboratory Inv, 2003, 83(12): 1811-1820

[14] Maxim A V, Jack A B, James A T, et al. Human embryonic stem cell-derived CD34+ cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 2005, 105(2): 617-626

[15] Junfeng J, Kausalia V, Marc B, et al. OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells, 2008, 26(10): 2485-2495

[16] Shulamit L, Ngan F H, Erin L, et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA, 2003, 100(22): 12741-12746

[17] Cho S W, Moon S H, Lee S H, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation, 2007, 116(21): 2409-2419

[18] Lu S J, Feng Q, Caballero S, et al. Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods, 2007, 4(6): 501-509

[19] Lu S J, Luo C, Holton K, et al. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regenerative Med, 2008, 3(5): 693-704

[20] Kim J, Moon S H, Lee S H, et al. Effective isolation and culture of endothelial cells in embryoid body differentiated from human embryonic stem cells. Stem Cells and Development, 2007, 16(2): 269-280

[21] Zambidis E T, Peault B, Park T S, et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood, 2005, 106(3): 860-870

[22] Sone M, Itoh H, Yamashita J, et al. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation, 2003, 107(16): 2085-2088

[23] Lu S J, Ivanova Y, Feng Q, et al. Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regenerative Med, 2009, 4(1): 37-47

[24] Patterson L J, Gering M, Patient R. Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood, 2005, 105:(9) 3502-3511

[25] Lugus J J, Chung Y S, Mills J C, et al. GATA2 functions at multiple steps in hemangioblast development and differentiation. Development, 2007, 134(2): 393-405

[26] Papanicolaou K N, Izumiya Y, Walsh K. Forkhead transcription factors and cardiovascular biology. Circ Res, 2008, 102(1): 16-31

[27] De Val S, Chi N C, Meadows S M, et al. Combinatorial regulation of endothelial transcription by Ets and Forkhead transcription factors. Cell, 2008, 135(6): 1053-1064

[28] Choi J, Dong L, Ahn J, et al. FoxH1 negatively modulates flk1 gene expression and vascular formation in zebrafish. Dev Biol, 2007, 304(2): 735-744

[29] Paik J H, Kollipara R, Chu G, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell, 2007, 128(2): 309-323

[30] Liu F, Walmsley M, Rodaway A, et al. Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol, 2008, 18(16): 1234-1240

[31] Ferdous A, Caprioli A, Iacovino M, et al. Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo. Proc Natl Acad Sci USA, 2009, 106(3): 814-819

[32] Lee D, Park C, Lee H, et al. ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell, 2008a, 2(5): 497-507

[33] De Val S, Anderson J P, Heidt A B, et al. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev Biol, 2004, 275(2): 424-434

[34] Ivey K N, Muth A, Arnold J, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2008, 2(3): 219-229

[35] Poliseno L, Tuccoli A, Mariani L, et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 2006, 108(9): 3068- 3071

[36] Woll P S, Morris J K, Painschab M S, et al. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood, 2008, 111(1): 122-131

[37] Kelly M A, Hirschi K K. Signaling hierarchy regulating human endothelial cell development. Arterioscler Thromb Vasc Biol, 2009, 29(5): 718-724

[38] Suzuki Y, Montagne K, Nishihara A, et al. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and Angiopoietin-1/Tie2 signalling. J Biochem, 2008, 143(2): 199-206

[39] Dingcheng G, Daniel J N, Albert S M, et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science, 2008, 319(5860): 195-198

[40] Peters B A, Diaz L A, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nature Med, 2005, 11(3): 261-262

[41] Xu D, Alipio Z, Fink LM, et al. Phenotypic correction of murine hemophilia a using an ips cell-based therapy. Proc Natl Acad Sci USA, 2009, 106(3): 808-813

[42] Sasaki H, Ishikawa M, Tanaka N, et al. Administration of human peripheral blood-derived cd133+ cells accelerates functional recovery in a rat spinal cord injury model. Spine, 2009, 34(3): 249-254

[43] Rauch M F, Hynes S R, Bertram J, et al. Engineering angiogenesis following spinal cord injury: A coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrier. European J Neuroscience, 2009, 29(1): 132-145

[44] Jeong J O, Kim M O, Kim H, et al. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation, 2009, 119(5): 699-708

[45] Kim S S, Park M S, Cho S W, et al. Enhanced bone formation by marrow-derived endothelial and osteogenic cell transplantation. J Biomed Mater Res A, 2010, 92(1): 246-253

[46] Santo S D, Tepper O M, von Ballmoos M W, et al. Cell-based therapy facilitates venous thrombus resolution. Thrombosis and Haemostasis, 2009, 101(3): 460-464

[47] Aninda B, Alan G C, Dipak D, et al. Overexpression of vascular endothelial growth factor and the development of post- transplantation cancer. Cancer Research, 2008, 68(14): 5689-5698

[48] Zhu J H, Wang X X, Zhang F R, et al. Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study. Pediatric Transplantation, 2008, 12(6): 650-655

PDF